Neurotoxicity Research

, Volume 15, Issue 1, pp 82–95 | Cite as

The Mitochondrial ATP-Sensitive Potassium Channel Blocker 5-Hydroxydecanoate Inhibits Toxicity of 6-Hydroxydopamine on Dopaminergic Neurons

  • J. Rodriguez-Pallares
  • J. A. Parga
  • B. Joglar
  • M. J. Guerra
  • J. L. Labandeira-Garcia


The neurotoxin 6-hydroxydopamine is commonly used in models of Parkinson’s disease, and a potential factor in the pathogenesis of the disease. However, the mechanisms responsible for 6-hydroxydopamine-induced dopaminergic degeneration have not been totally clarified. Reactive oxygen species (ROS) derived from 6-OHDA uptake and intraneuronal autooxidation, extracellular 6-OHDA autooxidation, and microglial activation have been involved. The mitochondrial implication is controversial. Mitochondrial ATP-sensitive K (mitoK(ATP)) channels may provide a convergent target that could integrate these different mechanisms. We observed that in primary mesencephalic cultures and neuron-enriched cultures, treatment with the mitoK(ATP) channel blocker 5-hydroxydecanoate, inhibits the dopaminergic degeneration induced by low doses of 6-OHDA. Furthermore, 5-hydroxydecanoate blocks the 6-OHDA-induced decrease in mitochondrial inner membrane potential and inhibits 6-OHDA-induced generation of superoxide-derived ROS in dopaminergic neurons. The results suggest that low doses of 6-OHDA may generate low levels of ROS through several mechanisms, which may be insufficient to induce neuron death. However, they could act as a trigger to activate mitoK(ATP) channels, thereby enhancing ROS production and the subsequent dopaminergic degeneration. Furthermore, the present study provides additional data for considering mitoK(ATP) channels as a potential target for neuroprotection.


6-OHDA Mitok(ATP) channels Dopamine Parkinson’s disease Oxidative stress Mitochondria Neurodegeneration 



This study was funded by Spanish Ministry of Education (MEC, BFU2006-07414/BFI), Spanish Ministry of Health (RD06/0010/0013 and Ciberned), and Galician Government (XUGA). The authors thank Pilar Aldrey for her excellent technical assistance.


  1. Abad F, Maroto R, López MG, Sánchez-García P, García AG (1995) Pharmacological protection against the cytotoxicity induced by 6-hydroxydopamine and H2O2 in chromaffin cells. Eur J Pharmacol 293:55–64PubMedCrossRefGoogle Scholar
  2. Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence. Nat Med 10:S18–S25PubMedCrossRefGoogle Scholar
  3. Andrew R, Watson DG, Best SA, Midgley JM, Wenlong H, Petty RKH (1993) The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res 18:1175–1177PubMedCrossRefGoogle Scholar
  4. Andrukhiv A, Costa AD, West IC, Garlid KD (2006) Opening mitoKATP increases superoxide generation from complex I of the electron transport chain. Am J Physiol Heart Circ Physiol 291:H2067–H2074PubMedCrossRefGoogle Scholar
  5. Avshalumov MV, Rice ME (2003) Activation of ATP-sensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release. Proc Natl Acad Sci USA 100:11729–11734PubMedCrossRefGoogle Scholar
  6. Avshalumov MV, Chen BT, Marshall SP, Peña DM, Rice ME (2003) Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2. J Neurosci 23:2744–2750PubMedGoogle Scholar
  7. Avshalumov MV, Chen BT, Koós T, Tepper JM, Rice ME (2005) Endogenous hydrogen peroxide regulates the excitability of midbrain dopamine neurons via ATP-sensitive potassium channels. J Neurosci 25:4222–4231PubMedCrossRefGoogle Scholar
  8. Berretta N, Freestone PS, Guatteo E, de Castro D, Geracitano R, Bernardi G, Mercuri NB, Lipski J (2005) Acute effects of 6-hydroxydopamine on dopaminergic neurons of the rat substantia nigra pars compacta in vitro. Neurotoxicology 26:869–881PubMedCrossRefGoogle Scholar
  9. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci 3:1301–1306PubMedCrossRefGoogle Scholar
  10. Block ML, Hong JS (2005) Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76:77–98PubMedCrossRefGoogle Scholar
  11. Blum D, Torch S, Nissou MF, Benabid AL, Verna JM (2000) Extracellular toxicity of 6-hydroxydopamine on PC12 cells. Neurosci Lett 283:193–196PubMedCrossRefGoogle Scholar
  12. Brown PC, Sokolove PM, McCann DJ, Stevens JL, Jones TW (1996) Induction of a permeability transition in rat kidney mitochondria by pentachlorobutadienyl cysteine: a beta-lyase-independent process. Arch Biochem Biophys 331:225–231PubMedCrossRefGoogle Scholar
  13. Busija DW, Lacza Z, Rajapakse N, Shimizu K, Kis B, Bari F, Domoki F, Horiguchi T (2004) Targeting mitochondrial ATP-sensitive potassium channels-a novel approach to neuroprotection. Brain Res Brain Res Rev 46:282–294PubMedCrossRefGoogle Scholar
  14. Costa AD, Garlid KD (2008) Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT. Am J Physiol Heart Circ Physiol 295:H874–H882PubMedCrossRefGoogle Scholar
  15. Dodel RC, Du Y, Bales KR, Ling Z, Carvey PM, Paul SM (1999) Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Brain Res Mol Brain Res 64:141–148PubMedCrossRefGoogle Scholar
  16. Facundo HT, Carreira RS, de Paula JG, Santos CC, Ferranti R, Laurindo FR, Kowaltowski AJ (2005) Ischemic preconditioning requires increases in reactive oxygen release independent of mitochondrial K+ channel activity. Free Radic Biol Med 40:469–479PubMedCrossRefGoogle Scholar
  17. Gao HM, Liu B, Zhang W, Hong JS (2003a) Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson’s disease. FASEB J 17:1957–1959PubMedGoogle Scholar
  18. Gao HM, Hong JS, Zhang W, Liu B (2003b) Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson’s disease. J Neurosci 23:1228–1236PubMedGoogle Scholar
  19. Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D’Alonzo AJ, Lodge NJ, Smith MA, Grover GJ (1997) Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res 81:1072–1082PubMedGoogle Scholar
  20. Gáspár T, Snipes JA, Busija AR, Kis B, Domoki F, Bari F, Busija DW (2008) ROS-independent preconditioning in neurons via activation of mitoK(ATP) channels by BMS-191095. J Cereb Blood Flow Metab 28:1090–1103PubMedCrossRefGoogle Scholar
  21. Glinka YY, Youdim MB (1995) Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur J Pharmacol 292:329–332PubMedGoogle Scholar
  22. Glinka Y, Tipton KF, Youdim MB (1996) Nature of inhibition of mitochondrial respiratory complex I by 6-Hydroxydopamine. J Neurochem 66:2004–2010PubMedGoogle Scholar
  23. Glinka Y, Gassen M, Youdim MB (1997) Mechanism of 6-hydroxydopamine neurotoxicity. J Neural Transm Suppl 50:55–66PubMedGoogle Scholar
  24. Gonzalez-Hernandez T, Barroso-Chinea P, De La Cruz Muros I, Del Mar Perez-Delgado M, Rodriguez M (2004) Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. J Comp Neurol 479:198–215PubMedCrossRefGoogle Scholar
  25. Gottlieb E, Armour SM, Harris MH, Thompson CB (2003) Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ 10:709–717PubMedCrossRefGoogle Scholar
  26. Graham DG, Tiffany SM, Bell WR Jr, Gutknecht WF (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 14:644–653PubMedGoogle Scholar
  27. Han J, Kim N, Park J, Seog DH, Joo H, Kim E (2002) Opening of mitochondrial ATP-sensitive potassium channels evokes oxygen radical generation in rabbit heart slices. J Biochem 131:721–727PubMedGoogle Scholar
  28. Hanley PJ, Daut J (2005) K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms. J Mol Cell Cardiol 39:17–50PubMedCrossRefGoogle Scholar
  29. Hanrott K, Gudmunsen L, O’Neill MJ, Wonnacott S (2006) 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta. J Biol Chem 281:5373–5382PubMedCrossRefGoogle Scholar
  30. Hirsch EC, Faucheux B, Damier P, Mouatt-Prigent A, Agid Y (1997) Neuronal vulnerability in Parkinson’s disease. J Neural Transm Suppl 50:79–88PubMedGoogle Scholar
  31. Irwin I, Langston JW (1995) Endogenous toxins as potential etiologic agents in Parkinson’s disease. In: Ellenberg JH, Koller WC, Langston JW (eds) Etiology of Parkinson’s disease. Marcel Dekker Inc.., New York, pp 153–201Google Scholar
  32. Jellinger KA (2000) Cell death mechanisms in Parkinson’s disease. J Neural Transm 107:1–29PubMedCrossRefGoogle Scholar
  33. Jellinger K, Linert L, Kienzl E, Herlinger E, Youdim MBH (1995) Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson’s disease. J Neural Transm 46:297–314Google Scholar
  34. Kawabata H, Ryomoto T, Ishikawa K (2001) Role of cardiac ATP-sensitive K+ channels induced by HMG CoA reductase inhibitor in ischemic rabbit hearts. Hypertens Res 24:573–577PubMedCrossRefGoogle Scholar
  35. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, Suzuki T, Maeta H, Abe Y (2005a) Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension 45:860–866PubMedCrossRefGoogle Scholar
  36. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, Abe Y (2005b) Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension 45:438–444PubMedCrossRefGoogle Scholar
  37. Kis B, Rajapakse NC, Snipes JA, Nagy K, Horiguchi T, Busija DW (2003) Diazoxide induces delayed pre-conditioning in cultured rat cortical neurons. J Neurochem 87:969–980PubMedCrossRefGoogle Scholar
  38. Kumar R, Agarwal AK, Seth PK (1995) Free radical-generated neurotoxicity of 6-hydroxydopamine. J Neurochem 64:1703–1707PubMedCrossRefGoogle Scholar
  39. Linert W, Herlinger E, Jameson RF, Kienzl E, Jellinger K, Youdim MBH (1996) Dopamine, 6-hydroxydopamine, iron, dioxygen—their mutual interactions and possible implication in the development of Parkinson’s disease. Biochim Biophys Acta 1316:160–168PubMedGoogle Scholar
  40. Liss B, Haeckel O, Wildmann J, Miki T, Seino S, Roeper J (2005) K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat Neurosci 8:1742–1751PubMedCrossRefGoogle Scholar
  41. Liu Y, Gutterman DD (2002) The coronary circulation in diabetes: influence of reactive oxygen species on K+ channel-mediated vasodilation. Vascul Pharmacol 38:43–49PubMedCrossRefGoogle Scholar
  42. Lotharius J, Dugan LL, O’Malley KL (1999) Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci 19:1284–1293PubMedGoogle Scholar
  43. Luthman J, Fredriksson A, Sundstrom E, Jonsson G, Archer T (1989) Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage. Behav Brain Res 33:267–277PubMedCrossRefGoogle Scholar
  44. Mattson MP, Liu D (2003) Mitochondrial potassium channels and uncoupling proteins in synaptic plasticity and neuronal cell death. Biochem Biophys Res Commun 304:539–549PubMedCrossRefGoogle Scholar
  45. McCullough JR, Normandin DE, Conder ML, Sleph PG, Dzwonczyk S, Grover GJ (1991) Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ Res 69:949–958PubMedGoogle Scholar
  46. McRitchie DA, Hardman CD, Halliday GM (1996) Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J Comp Neurol 364:121–150PubMedCrossRefGoogle Scholar
  47. Michel PP, Ruberg M, Agid G (1997) Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside. J Neurochem 69:1459–1507Google Scholar
  48. Minners J, Lacerda L, Yellon DM, Opie LH, McLeod CJ, Sack MN (2007) Diazoxide-induced respiratory inhibition—a putative mitochondrial K(ATP) channel independent mechanism of pharmacological preconditioning. Mol Cell Biochem 294:11–18PubMedCrossRefGoogle Scholar
  49. Obata T, Yamanaka Y (2000) Block of cardiac ATP-sensitive K(+) channels reduces hydroxyl radicals in the rat myocardium. Arch Biochem Biophys 378:195–200PubMedCrossRefGoogle Scholar
  50. Oldenburg O, Cohen MV, Yellon DM, Downey JM (2002) Mitochondrial K(ATP) channels: role in cardioprotection. Cardiovasc Res 55:429–437PubMedCrossRefGoogle Scholar
  51. Przedborski S, Jackson-Lewis V (1998) Experimental developments in movement disorders: update on proposed free radical mechanisms. Curr Opin Neurol 11:335–339PubMedCrossRefGoogle Scholar
  52. Ramasarma T (1982) Generation of H2O in biomembranes. Biochim Biophys Acta 694:69–93PubMedGoogle Scholar
  53. Reinhardt R, Manaenko A, Guenther A, Franke H, Dickel T, Garcia de Arriba S, Muench G, Schneider D, Wagner A, Illes P (2003) Early biochemical and histological alterations in rat corticoencephalic cell cultures following metabolic damage and treatment with modulators of mitochondrial ATP-sensitive potassium channels. Neurochem Int 43:563–571PubMedCrossRefGoogle Scholar
  54. Rodriguez-Pallares J, Parga JA, Muñoz A, Rey P, Guerra MJ, Labandeira-Garcia JL (2007) Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons. J Neurochem 103:145–156PubMedGoogle Scholar
  55. Rogers JH (1992) Immunohistochemical markers in rat brain: colocalization of calretinin and calbindin-D28k with tyrosine hydroxylase. Brain Res 587:203–210PubMedCrossRefGoogle Scholar
  56. Sachs C, Jonsson G (1975) Mechanisms of action of 6-hydroxydopamine. Biochem Pharmacol 24:1–8PubMedCrossRefGoogle Scholar
  57. Senoh S, Creveling CR, Udenfriend S, Witkop B (1959) Chemical, enzymatic and metabolic studies on the mechanism of oxidation of dopamine. J Am Chem Soc 81:6236–6240CrossRefGoogle Scholar
  58. Simola N, Morelli M, Carta AR (2007) The 6-hydroxydopamine model of Parkinson’s disease. Neurotox Res 11:151–167PubMedCrossRefGoogle Scholar
  59. Soto-Otero R, Méndez-Álvarez E, Hermida-Ameijeiras A, Muñoz-Patiño A, Labandeira-García JL (2000) Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson’s disease. J Neurochem 74:1605–1612PubMedCrossRefGoogle Scholar
  60. Storch A, Kaftan A, Burkhardt K, Schwarz J (2000) 6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism. J Neural Transm 107:81–93CrossRefGoogle Scholar
  61. Sugrue MM, Wang Y, Rideout HJ, Chalmers-Redman RM, Tatton WG (1999) Reduced mitochondrial membrane potential and altered responsiveness of a mitochondrial membrane megachannel in p53-induced senescence. Biochem Biophys Res Commun 261:123–1230PubMedCrossRefGoogle Scholar
  62. Thomzig A, Wenzel M, Karschin C, Eaton MJ, Skatchkov SN, Karschin A, Veh RW (2001) Kir6.1 is the principal pore-forming subunit of astrocyte but not neuronal plasma membrane K-ATP channels. Mol Cell Neurosci 18:671–690PubMedCrossRefGoogle Scholar
  63. Tokube K, Kiyosue T, Arita M (1998) Effects of hydroxyl radicals on KATP channels in guinea-pig ventricular myocytes. Pflugers Arch 437:155–157PubMedCrossRefGoogle Scholar
  64. Wadia JS, Chalmers-Redman RM, Ju WJ, Carlile GW, Phillips JL, Fraser AD, Tatton WG (1998) Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (−)-deprenyl. J Neurosci 18:932–947PubMedGoogle Scholar
  65. Wu Y, Blum D, Nissou MF, Benabid AL, Verna JM (1996) Unlike MPP+, apoptosis induced by 6-OHDA in PC12 cells is independent of mitochondrial inhibition. Neurosci Lett 221:69–71PubMedCrossRefGoogle Scholar
  66. Wu J, Hu J, Chen YP, Takeo T, Suga S, Dechon J, Liu Q, Yang KC, St John PA, Hu G, Wang H, Wakui M (2006) Iptakalim modulates ATP-sensitive K(+) channels in dopamine neurons from rat substantia nigra pars compacta. J Pharmacol Exp Ther 319:155–164PubMedCrossRefGoogle Scholar
  67. Xia Y, Haddad GG (1991) Major differences in CNS sulfonylurea receptor distribution between the rat (newborn, adult) and turtle. J Comp Neurol 314:278–289PubMedCrossRefGoogle Scholar
  68. Yamauchi T, Kashii S, Yasuyoshi H, Zhang S, Honda Y, Akaike A (2003) Mitochondrial ATP-sensitive potassium channel: a novel site for neuroprotection. Invest Ophthalmol Vis Sci 44:2750–2756PubMedCrossRefGoogle Scholar
  69. Yellon DM, Downey JM (2003) Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83:1113–1151PubMedGoogle Scholar
  70. Zhang HY, McPherson BC, Liu H, Baman TS, Rock P, Yao Z (2002) H(2)O(2) opens mitochondrial K(ATP) channels and inhibits GABA receptors via protein kinase C-epsilon in cardiomyocytes. Am J Physiol Heart Circ Physiol 282:H1395–H1403PubMedGoogle Scholar
  71. Zhang L, Li L, Prabhakaran K, Borowitz JL, Isom GE (2006) Trimethyltin-induced apoptosis is associated with upregulation of inducible nitric oxide synthase and Bax in a hippocampal cell line. Toxicol Appl Pharmacol 216:34–43PubMedCrossRefGoogle Scholar
  72. Zhang GX, Lu XM, Kimura S, Nishiyama A (2007) Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation. Cardiovasc Res 76:204–212PubMedCrossRefGoogle Scholar
  73. Zhou M, Tanaka O, Suzuki M, Sekiguchi M, Takata K, Kawahara K, Abe H (2002) Localization of pore-forming subunit of the ATP-sensitive K(+)-channel, Kir6.2, in rat brain neurons and glial cells. Brain Res Mol Brain Res 101:23–32PubMedCrossRefGoogle Scholar
  74. Zini S, Tremblay E, Pollard H, Moreau J, Ben-Ari Y (1993) Regional distribution of sulfonylurea receptors in the brain of rodent and primate. Neuroscience 55:1085–1091PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • J. Rodriguez-Pallares
    • 1
    • 2
  • J. A. Parga
    • 1
    • 2
  • B. Joglar
    • 1
    • 2
  • M. J. Guerra
    • 1
    • 2
  • J. L. Labandeira-Garcia
    • 1
    • 2
  1. 1.Laboratory of Neuroanatomy and Experimental Neurology, Department of Morphological Sciences, Faculty of MedicineUniversity of Santiago de CompostelaSantiagoSpain
  2. 2.Networking Research Center on Neurodegenerative Diseases (CIBERNED)SevillaSpain

Personalised recommendations